Review of Late-Breaking Trials From CRT 2021 Virtual.
作者信息
Medranda Giorgio A, Case Brian C, Wermers Jason P, Morrison Natalie, Waksman Ron
机构信息
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
出版信息
Cardiovasc Revasc Med. 2021 Jul;28S:3-8. doi: 10.1016/j.carrev.2021.03.016. Epub 2021 Mar 23.
Abstract
摘要
相似文献
1
Review of Late-Breaking Trials From CRT 2021 Virtual.CRT 2021虚拟会议的最新试验综述。
Cardiovasc Revasc Med. 2021 Jul;28S:3-8. doi: 10.1016/j.carrev.2021.03.016. Epub 2021 Mar 23.
2
Stent Thrombosis During TAVR.经导管主动脉瓣置换术期间的支架血栓形成
JACC Cardiovasc Interv. 2020 Mar 23;13(6):e45-e47. doi: 10.1016/j.jcin.2019.09.052. Epub 2019 Nov 27.
3
Review of Late-Breaking Trials From CRT 2023.CRT 2023最新试验综述。
Cardiovasc Revasc Med. 2023 Aug;53S:S3-S9. doi: 10.1016/j.carrev.2023.04.017. Epub 2023 Apr 25.
4
In-stent restenosis percutaneous coronary intervention after chimney stenting during transcatheter aortic valve-in-valve implantation.经导管主动脉瓣中瓣植入术中烟囱支架置入后经皮冠状动脉介入治疗的支架内再狭窄
EuroIntervention. 2023 Jun 5;19(2):e191-e192. doi: 10.4244/EIJ-D-22-00891.
5
Delayed coronary obstruction following Portico in Freedom Solo valve-in-valve implantation.Portico Freedom Solo 瓣中瓣植入术后延迟性冠状动脉阻塞
Coron Artery Dis. 2017 Sep;28(6):528-529. doi: 10.1097/MCA.0000000000000487.
6
Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement: Approach and Challenges.经导管主动脉瓣置换术后的经皮冠状动脉介入治疗：方法与挑战。
J Am Coll Cardiol. 2016 Jul 26;68(4):432-3. doi: 10.1016/j.jacc.2016.04.051.
7
IVUS Imaging of Endothelialization of an Implanted Transcatheter Aortic Valve Causing Delayed Coronary Obstruction.植入经导管主动脉瓣内皮化导致延迟性冠状动脉阻塞的血管内超声成像
JACC Cardiovasc Interv. 2023 Aug 28;16(16):2040-2042. doi: 10.1016/j.jcin.2023.04.038. Epub 2023 Jun 7.
8
Feasibility of selective coronary angiography and percutaneous coronary intervention following self-expanding transcatheter aortic valve replacement: a systematic review and meta-analysis.自膨胀经导管主动脉瓣置换术后选择性冠状动脉造影和经皮冠状动脉介入治疗的可行性：一项系统评价和荟萃分析。
Coron Artery Dis. 2022 Dec 1;33(8):678-681. doi: 10.1097/MCA.0000000000001182. Epub 2022 Oct 14.
9
Coronary Access and PCI After Chimney Stenting During Self-Expanding Transcatheter Aortic Valve Replacement in Surgical Bioprosthesis.外科生物瓣经皮自膨胀式主动脉瓣置换术中烟囱支架置入术后的冠状动脉通路与经皮冠状动脉介入治疗
JACC Cardiovasc Interv. 2022 Aug 8;15(15):1585-1589. doi: 10.1016/j.jcin.2022.05.015. Epub 2022 Jun 15.
10
Late-Phase Delayed Coronary Obstruction Caused by Protruding Calcified Aortic Valve Leaflet After Balloon-Expandable Transcatheter Aortic Valve Replacement.球囊扩张式经导管主动脉瓣置换术后钙化主动脉瓣叶突出导致的晚期延迟冠状动脉阻塞
Circ Cardiovasc Imaging. 2021 Sep;14(9):e012854. doi: 10.1161/CIRCIMAGING.121.012854. Epub 2021 Aug 27.
本文引用的文献
1
Preprocedural Colchicine in Patients With Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (PodCAST-PCI).接受经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者术前使用秋水仙碱：一项随机对照试验（PodCAST-PCI）
J Cardiovasc Pharmacol. 2022 Oct 1;80(4):592-599. doi: 10.1097/FJC.0000000000001317.
2
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA Registry.经导管主动脉瓣置换术中预防冠状动脉阻塞：多中心国际 BASILICA 注册研究结果。
JACC Cardiovasc Interv. 2021 May 10;14(9):941-948. doi: 10.1016/j.jcin.2021.02.035. Epub 2021 Mar 6.
3
Biodegradable- Versus Durable-Polymer DES in ST-Segment Elevation Myocardial Infarction: Time to Update Our a Priori Beliefs?生物可降解聚合物与耐用聚合物药物洗脱支架在ST段抬高型心肌梗死中的应用：是时候更新我们的先验观念了吗？
JACC Cardiovasc Interv. 2021 Mar 22;14(6):649-652. doi: 10.1016/j.jcin.2021.01.031.
4
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial.生物可降解聚合物药物洗脱支架与耐久性聚合物药物洗脱支架治疗 ST 段抬高型心肌梗死：BIOSTEMI 试验的最终 2 年结果。
JACC Cardiovasc Interv. 2021 Mar 22;14(6):639-648. doi: 10.1016/j.jcin.2020.12.011.
5
The BASILICA Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction.BASILICA 试验：旨在通过主动撕裂瓣叶预防 TAVR 冠状动脉阻塞的前瞻性多中心研究。
JACC Cardiovasc Interv. 2019 Jul 8;12(13):1240-1252. doi: 10.1016/j.jcin.2019.03.035. Epub 2019 Jun 12.
6
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial.吸收性生物可吸收支架与依维莫司洗脱金属支架预防再狭窄高危患者经皮冠状动脉介入治疗后再狭窄的比较：COMPARE ABSORB试验的原理与设计
Cardiovasc Revasc Med. 2019 Jul;20(7):577-582. doi: 10.1016/j.carrev.2019.04.013. Epub 2019 Apr 16.
Zotero 插件